{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:34:55Z","timestamp":1783114495244,"version":"3.54.6"},"reference-count":64,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["CRSII3_147697"],"award-info":[{"award-number":["CRSII3_147697"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is a cancer associated with exposure to asbestos fibers, which accumulate in the pleural space, damage tissue and stimulate regeneration. Hedgehog signaling is a pathway important during embryonic mesothelium development and is inactivated in adult mesothelium. The pathway is reactivated in some MPM patients with poor clinical outcome, mainly mediated by the expression of the ligands. Nevertheless, mutations in components of the pathway have been observed in a few cases. Data from different MPM animal models and primary culture suggest that both autocrine and paracrine Hedgehog signaling are important to maintain tumor growth. Drugs inhibiting the pathway at the level of the smoothened receptor (Smo) or glioma-associated protein transcription factors (Gli) have been used mostly in experimental models. For clinical development, biomarkers are necessary for the selection of patients who can benefit from Hedgehog signaling inhibition.<\/jats:p>","DOI":"10.3390\/genes6030500","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T10:10:02Z","timestamp":1436350202000},"page":"500-511","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hedgehog Signaling in Malignant Pleural Mesothelioma"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-0294","authenticated-orcid":false,"given":"Emanuela","family":"Felley-Bosco","sequence":"first","affiliation":[{"name":"University Hospital Zurich, Laboratory of Molecular Oncology, Clinic of Oncology, Haeldeliweg 4, 8044 Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[{"name":"University Hospital Zurich, Division of Thoracic Surgery, Raemistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayura","family":"Meerang","sequence":"additional","affiliation":[{"name":"University Hospital Zurich, Division of Thoracic Surgery, Raemistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global magnitude of reported and unreported mesothelioma","volume":"119","author":"Park","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"ref_2","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the north western cape province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br. J. Ind. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12094-011-0699-5","article-title":"Seom guidelines for the treatment of malignant pleural mesothelioma","volume":"13","author":"Lianes","year":"2011","journal-title":"Clin. Transl. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.ejca.2007.09.018","article-title":"Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the italian register","volume":"43","author":"Marinaccio","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The european mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","article-title":"The pathogenesis of mesothelioma","volume":"29","author":"Carbone","year":"2002","journal-title":"Semin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline bap1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase iii study of pemetrexed in combination with cisplatin vs. cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","article-title":"Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma","volume":"22","author":"Weder","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jtcvs.2013.01.039","article-title":"The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the international mesothelioma interest group congress, 11\u201314 September 2012, Boston, Mass","volume":"145","author":"Rusch","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.lungcan.2013.04.024","article-title":"Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma","volume":"81","author":"Cao","year":"2013","journal-title":"Lung Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/JTO.0b013e3181ed0489","article-title":"A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"5","author":"Cao","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","first-page":"428","article-title":"Systematic review of trimodality therapy for patients with malignant pleural mesothelioma","volume":"1","author":"Cao","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/ers.11.1","article-title":"Photodynamic therapy for malignant pleural mesothelioma: The future of treatment?","volume":"5","author":"Friedberg","year":"2011","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jtcvs.2009.02.046","article-title":"Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study","volume":"138","author":"Tilleman","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_16","first-page":"343","article-title":"Mo 14.05 intracavitary cisplatin-fibrin chemotherapy after resection for malignant pleural mesothelioma patients (influence-meso)\u2014Preliminary results","volume":"8","author":"Opitz","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Stahel, R.A., Weder, W., Felley-Bosco, E., Petrausch, U., Curioni-Fontecedro, A., Schmitt-Opitz, I., and Peters, S. (2015). Searching for targets for the systemic therapy of mesothelioma. Ann. Oncol.","DOI":"10.1093\/annonc\/mdv101"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","article-title":"Role of hedgehog signaling in malignant pleural mesothelioma","volume":"18","author":"Shi","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1242\/dev.083691","article-title":"Roles for hedgehog signaling in adult organ homeostasis and repair","volume":"141","author":"Petrova","year":"2014","journal-title":"Development"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/17611","article-title":"Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein","volume":"397","author":"Chuang","year":"1999","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.devcel.2005.12.013","article-title":"Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian hedgehog signaling pathway","volume":"10","author":"Svard","year":"2006","journal-title":"Dev. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1242\/dev.02021","article-title":"Cardiac and cns defects in a mouse with targeted disruption of suppressor of fused","volume":"132","author":"Cooper","year":"2005","journal-title":"Development"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nature04117","article-title":"Vertebrate smoothened functions at the primary cilium","volume":"437","author":"Corbit","year":"2005","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1242\/dev.098079","article-title":"Derivation of lung mesenchymal lineages from the fetal mesothelium requires hedgehog signaling for mesothelial cell entry","volume":"140","author":"Dixit","year":"2013","journal-title":"Development"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, Y., He, J., Zhang, F., Li, H., Yue, D., Wang, C., Jablons, D.M., He, B., and Lui, N. (2013). SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma. J. Exp. Clin. Cancer Res.","DOI":"10.1186\/1756-9966-32-7"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/bioinformatics\/btt085","article-title":"Nozzle: A report generation toolkit for data analysis pipelines","volume":"29","author":"Gehlenborg","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_27","unstructured":"Broad institute tcga genome data analysis center (2014): Paradigm pathway analysis of mrnaseq expression and copy number data. Available online:http:\/\/gdac.broadinstitute.org\/runs\/analyses__2014_10_17\/reports\/cancer\/MESO-TP\/Pathway_Paradigm_RNASeq_And_Copy_Number\/nozzle.html."},{"key":"ref_28","unstructured":"Broad institute tcga genome data analysis center (2014): Clustering of mrnaseq gene expression: Consensus nmf. Available online:http:\/\/gdac.broadinstitute.org\/runs\/analyses__2014_10_17\/reports\/cancer\/MESO-TP\/mRNAseq_Clustering_Consensus_Plus\/nozzle.html."},{"key":"ref_29","unstructured":"Broad institute tcga genome data analysis center (2014): Correlation between aggregated molecular cancer subtypes and selected clinical features. Available online:http:\/\/gdac.broadinstitute.org\/runs\/analyses__2014_10_17\/reports\/cancer\/MESO-TP\/Correlate_Clinical_vs_Molecular_Subtypes\/nozzle.html."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e66685","DOI":"10.1371\/journal.pone.0066685","article-title":"Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma","volume":"8","author":"Lim","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_31","first-page":"181","article-title":"Hedgehog beyond medulloblastoma and basal cell carcinoma","volume":"1805","author":"Teglund","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)65166-8","article-title":"DNA copy number losses in human neoplasms","volume":"155","author":"Knuutila","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1349-7006.1998.tb00649.x","article-title":"Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer","volume":"89","author":"Minobe","year":"1998","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_34","first-page":"2150","article-title":"Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including cdkn2","volume":"55","author":"Schultz","year":"1995","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2015.04.018","article-title":"Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment","volume":"335","author":"Islam","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Takebe, N., Miele, L., Harris, P.J., Jeong, W., Bando, H., Kahn, M., Yang, S.X., and Ivy, S.P. (2015). Targeting notch, hedgehog, and wnt pathways in cancer stem cells: Clinical update. Nat. Rev. Clin. Oncol.","DOI":"10.1038\/nrclinonc.2015.61"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The abc transporter bcrp1\/abcg2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1182\/blood.V99.2.507","article-title":"The abcg2 transporter is an efficient hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors","volume":"99","author":"Scharenberg","year":"2002","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/carcin\/bgr127","article-title":"Pleural mesothelioma side populations have a precursor phenotype","volume":"32","author":"Frei","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/0008-5472.CAN-05-4505","article-title":"Shh pathway activity is down-regulated in cultured medulloblastoma cells: Implications for preclinical studies","volume":"66","author":"Sasai","year":"2006","journal-title":"Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","article-title":"Identification and expansion of human colon-cancer-initiating cells","volume":"445","author":"Lombardi","year":"2007","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cub.2006.11.033","article-title":"Hedgehog-gli1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity","volume":"17","author":"Clement","year":"2007","journal-title":"Curr. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb1024","article-title":"Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts","volume":"5","author":"Parrinello","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Renganathan, A., Kresoja-Rakic, J., Echeverry, N., Ziltener, G., Vrugt, B., Opitz, I., Stahel, R.A., and Felley-Bosco, E. (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Mol. Cancer.","DOI":"10.1186\/1476-4598-13-119"},{"key":"ref_46","unstructured":"Meerang, M., B\u00e9rard, K., Felley-Bosco, E., Vrugt, B., Boss, A., Kenkel, D., Broggini-Tenzel, A., Stahel, R., Lauk, O., and Arni, S. (2015). Effects of vismodegib in an orthotopic immunocompetent rat model of malignant pleural mesothelioma, Unpublished data."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature07275","article-title":"A paracrine requirement for hedgehog signalling in cancer","volume":"455","author":"Yauch","year":"2008","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1038\/onc.2009.220","article-title":"Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer","volume":"28","author":"Bailey","year":"2009","journal-title":"Oncogene"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11786","DOI":"10.1074\/jbc.M112.438846","article-title":"Loss of the transcription factor gli1 identifies a signaling network in the tumor microenvironment mediating kras oncogene-induced transformation","volume":"288","author":"Mills","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3389","article-title":"Unraveling the therapeutic potential of the hedgehog pathway in cancer","volume":"19","author":"Amakye","year":"2013","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","article-title":"Phase i trial of hedgehog pathway inhibitor vismodegib (gdc-0449) in patients with refractory, locally advanced or metastatic solid tumors","volume":"17","author":"LoRusso","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1158\/1078-0432.CCR-13-1711","article-title":"A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma","volume":"21","author":"Shou","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.semcdb.2014.05.003","article-title":"Context-dependent signal integration by the gli code: The oncogenic load, pathways, modifiers and implications for cancer therapy","volume":"33","author":"Aberger","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of pten-pi3k pathway and downstream proteins in malignant pleural mesothelioma (mpm)","volume":"77","author":"Cedres","year":"2012","journal-title":"Lung Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/JTO.0000000000000055","article-title":"Pi3k\/mtor signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy","volume":"9","author":"Bitanihirwe","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccr.2011.12.028","article-title":"The crosstalk of mtor\/s6k1 and hedgehog pathways","volume":"21","author":"Wang","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.1006822107","article-title":"Arsenic antagonizes the hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector","volume":"107","author":"Kim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1172\/JCI42874","article-title":"Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking hedgehog\/gli pathway","volume":"121","author":"Beauchamp","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e69466","DOI":"10.1371\/journal.pone.0069466","article-title":"Arsenic trioxide prevents osteosarcoma growth by inhibition of gli transcription via DNA damage accumulation","volume":"8","author":"Nakamura","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.0609699104","article-title":"Inhibition of gli-mediated transcription and tumor cell growth by small-molecule antagonists","volume":"104","author":"Lauth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.18632\/oncotarget.4224","article-title":"Targeting the hedgehog signaling pathway in cancer: Beyond smoothened","volume":"6","author":"Gonnissen","year":"2015","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e57346","DOI":"10.1371\/journal.pone.0057346","article-title":"Gli as a novel therapeutic target in malignant pleural mesothelioma","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.18632\/oncotarget.2729","article-title":"Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis","volume":"6","author":"Lim","year":"2015","journal-title":"Oncotarget"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jtcvs.2013.08.035","article-title":"Targeting of the hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro","volume":"147","author":"You","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/6\/3\/500\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:48:54Z","timestamp":1760215734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/6\/3\/500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,8]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,9]]}},"alternative-id":["genes6030500"],"URL":"https:\/\/doi.org\/10.3390\/genes6030500","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,8]]}}}